Molnupiravir
- India
Covid antiviral drug Molnupiravir launched in India
New Delhi: Covid antiviral drug Molnupiravir was on Monday launched in India at Rs 1,399 for a five-day course for mild to moderate infection. Amid rising cases of new Covid variant Omicron…
- India
Corbevax, Covovax, Molnupiravir approved for restricted emergency
New Delhi: Expanding India’s basket of COVID-19 vaccines, the Central Drug Authority has approved Serum Institute of India’s vaccine Covovax, Biological E’s jab Corbevax and anti-Covid pill Molnupiravir for restricted use in…
